Clarivate

MAY 13, 2024

After staying relatively flat for several years, enrollment growth took off in 2021 after an expansion in federal subsidies for silver-level plans passed in the American Rescue Plan and was then renewed through 2025 in the Inflation Reduction Act. Pillo, Senior Healthcare Research and Data Analyst. The post The U.S.

Insurance 52

Insurance Marketing Healthcare Healthcare 52

Healthcare Success

NOVEMBER 7, 2022

Best-in-class healthcare marketers are already planning for next year. According to Axios, traditional pay-TV providers like Comcast, Verizon, and Dish Network have lost a staggering 25 million subscribers since 2012 and are expected to lose another 25 million by 2025. It helps show healthcare consumers you care. People are 1.6

Marketing 52

Marketing Media Healthcare Healthcare 52

PM360

JUNE 16, 2023

The healthcare industry has been transformed by the COVID-19 pandemic, and the diagnostic market is no exception. This has led to significant changes in the healthcare diagnostics market and has created new opportunities and challenges for pharma executives.

Marketing 52

Marketing Healthcare Healthcare Medical 52

Evolve Your Success

NOVEMBER 28, 2023

Charles discusses the importance of AI in healthcare and how it can collect and analyze real-time data to provide personalized treatment and disease management. Ready to explore the future of healthcare? What type of resistance do you guys get when you engage a decision-maker within one of these healthcare insurance companies?

Medical 52

Medical Medical sales Sales Patients 52

PM360

SEPTEMBER 28, 2022

In April 2022, we released an article describing proposed policies from the federal government that could impact prescription drug pricing. healthcare system with major implications for the Medicare Advantage and Medicare Part D programs. On August 16, 2022, President Biden signed the Inflation Reduction Act (IRA) into law.

Government 97

Government Manufacturing Prescription Marketing 97

Pharma Leaders

JUNE 9, 2023

Cosette Pharmaceuticals has acquired the worldwide rights to prescription drug, Intraros, from Endorecherche’s subsidiary Endoceutics. It is expected to be launched in Asian market in 2025. Intrarosa is said to be the only prescription drug that provides estrogen as well as androgen to treat moderate-to-severe dyspareunia.

Prescription 52

Prescription Distribution Pharma Pharmaceutical 52

Clarivate

AUGUST 20, 2024

Moreover, the initial set of negotiated prices represents the first step of a process that eventually will reshape the pricing and reimbursement landscape for prescription drugs under Medicare as CMS gradually replaces private payers as the chief negotiating partner for some of the drug industry’s largest-selling treatments.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52

World of DTC Marketing

JULY 28, 2022

Nationwide, prescription drug spending last year is estimated to be $328 billion among all payers, including private insurance, Medicare Part D, and patients’ out-of-pocket expenses. Nearly 9 in 10 older adults take prescription medication. Still, the pharma industry is fighting hard to keep it off the table.

Pharma 256

Pharma Prescription Pharmaceutical Manufacturing 256

Clarivate

OCTOBER 17, 2024

Healthcare delivery has not been the hottest topic on the campaign trail this election season, despite sharp policy differences between the candidates and parties. However, recommendations from the Heritage Foundation’s Project 2025 could influence policymaking under a Trump administration. During the Sept.

Healthcare 52

Healthcare Healthcare Government Insurance 52